P&G buys Merk’s consumer health business in EUR 3.4 bln deal

Newsroom 19/04/2018 | 10:35

Procter & Gamble said it will acquire the consumer health business of Merck KGaA for about EUR 3.4 billion in a transaction designed to help the multinational conglomerate expand its exposure to Latin American and Asian markets.

P&G also announced it would also terminate its consumer care joint venture with Teva Pharmaceutical Industries, PGT Healthcare, on July 1, saying P&G and Teva’s strategies were no longer aligned.

“This will help (Merck) focus on its pharma unit and refurbish its pipeline,” said Morgan Stanley analyst Vincent Meunier quoted by Reuters.

KGaA’s portfolio includes vitamin brands such as Femibion, Neurobion and Nasivin.

BR Magazine | Latest Issue

Download PDF or read online: September 2022 Issue | Business Review Magazine

The September 2022 issue of Business Review Magazine is now available in digital format, featuring the main cover story titled “Transilvania Investments paves its way to a sustainable
Newsroom | 21/09/2022 | 14:17

You will receive a download link for the latest issue of Business Review Magazine in PDF format, based on the completion of the form below.

I agree with the Privacy policy of business-review.eu
I agree with the storage and handling of my data by business-review.eu

Close ×

We use cookies for keeping our website reliable and secure, personalising content and ads, providing social media features and to analyse how our website is used.

Accept & continue